TACE
- 网络肝动脉化疗栓塞;肝动脉化疗栓塞术;肝动脉栓塞化疗;化疗栓塞;化疗
-
The influence and function of LPS on the TACE gene expression
LPS刺激对TACE基因表达和对TNF-α前体加工的影响
-
The control group was treated with TACE only .
对照组单纯行TACE治疗。
-
Relationship between Body Temperature and Water Intake after TACE
肝动脉化疗栓塞术后摄水量与体温的关系研究
-
Clinical Observation of the Blood Stagnation Before and After TACE Operation
TACE术前后血瘀程度变化观察
-
The study of shortening the time of bed rest in patients after TACE
缩短肝动脉化疗栓塞术后患者卧床时间的研究
-
Analysis of chemotherapy dose and effect in advanced hepatic carcinoma with TACE therapy
TACE术治疗中晚期原发性肝癌药物量效分析
-
Study on cell apoptosis and telomerase activity after treatment of different drug with TACE operation
肝动脉化疗栓塞术后细胞凋亡与端粒酶活性的研究
-
Changes of vascular alteration in primary carcinoma of liver patients after TACE
原发性肝癌经动脉化疗栓塞供血改变
-
Conclusion Radiotherapy combined with TACE was an effective method for advanced cardiac carcinoma .
结论动脉化疗栓塞结合放疗是一种治疗晚期贲门癌的有效方法。
-
Conclusion The history of several times TACE may be the high risk factor of HAT .
结论术前多次TACE史是移植术后发生肝动脉血栓的高危因素。
-
Clinical Research Progress of Treating Side Effects of TACE for Primary Liver Cancer with Traditional Chinese Medicine
参芪化瘀方配合TACE术治疗原发性肝的疗效观察及机理探讨中医药防治原发性肝癌TACE术后副反应的临床研究进展
-
Clinical study of TACE combined with metronomic chemotherapy for primary liver cancer
节拍性化疗联合TACE治疗原发性肝癌的临床观察
-
Study on capecitabine combined with TACE for advanced liver cancer
卡培他滨联合肝动脉插管化疗栓塞治疗中晚期肝癌的研究
-
Effect of the small dose epinephrine in TACE on the liver cancer
小剂量肾上腺素在肝动脉化疗栓塞中的应用
-
Mel had significant protection and treatment effect on the liver function damage after TACE .
Mel对TACE引起的肝功能损害有明显保护和治疗作用,可降低TACE后腹水的发生率。
-
The toxicity was little after TACE , and the patients have a good quality of life .
介入治疗术后药物毒副作用轻,生活质量良好。
-
TACE is feasible , safe and effective in treating hepatocellular carcinoma .
TACE治疗肝癌可行、安全、有效。
-
Clinical research on middle-high dose Thalidomide Combined TACE treatment of primary liver cancer
中大剂量沙利度胺联合TACE治疗原发性肝癌临床研究
-
The longest one from the latest TACE to survived time is 8 years .
末次TACE至存活最长8年。
-
Effect of TACE and TACE combined with PEI for primary liver cancer
肝动脉化疗栓塞与肝动脉化疗栓塞联合无水乙醇注射治疗原发性肝癌疗效比较
-
Progress in a Model of Hepatic VX 2 Tumor for TACE
兔VX2肝癌模型在TACE中的研究进展
-
The alleviation of TACE syndrome in liver cancer by Chinese herbs : a clinical research
中药减轻肝癌化疗栓塞术后综合征的临床研究
-
Arterial injury during TACE for hepatic cancer : its causes , manifestations and management
肝癌经肝动脉化疗栓塞术中肝动脉损伤的原因、表现及处理
-
Combination of TACE with molecularly targeted agent in management of advanced HCC
TACE联合分子靶向药物治疗原发性肝癌的研究进展
-
Combined TACE and PEI in the Treatment of Primary Hepatic Carcinoma : Results of 42 Cases
TACE联合PEI治疗原发性肝癌42例分析
-
Conclusion PMCT after TACE can significantly promote the efficacy of liver cancer treatment .
结论TACE后行PMCT可明显提高肝癌治疗的疗效。
-
Conclusion TACE combined with RFA might be more effective in the treatment of liver cancer .
结论化疗栓塞术结合射频消融术是治疗肝癌的一种有效的联合治疗手段。
-
The age were 17-72 years old when the first TACE was done , average is 51 years old .
首次TACE治疗时年龄17-72岁,平均51岁。
-
Objective To alleviate the digestive tract symptoms following TACE and increase the effectiveness .
目的为减轻肝动脉化疗栓塞术(TACE)病人消化道反应、提高疗效。
-
Objective To evaluate the treatment of hypervascular hepatic metastasis with TACE .
目的分析肝动脉化疗栓塞术(TACE)治疗富血供肝转移瘤的疗效。